Literature DB >> 21945398

Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies.

Celso E Gomez-Sanchez1, Mary Warden, Miriam T Gomez-Sanchez, Xu Hou, Elise P Gomez-Sanchez.   

Abstract

The mineralocorticoid receptor (MR) is a widely distributed ligand activated nuclear transcription factor that is bound by various chaperone proteins that alter its conformation depending upon its location in the cell and whether it is ligand-bound. We describe the development and characterization of new monoclonal antibodies produced against a rat recombinant protein corresponding to aminoacids 5-550 of the MR to produce antibodies that recognize the receptor in specific conformations. Most of the resulting monoclonal antibodies studied were similar to those we produced by immunization with peptide isotopes, however two detected a single band at the appropriate molecular mass as the MR and had distinct immunostaining characteristics in neurons. One labeled cytosolic MR, the other labeled membranes and cytosol, including axons. These antibodies will permit study of the subcellular localization of the MR under various physiological and pathological conditions. We have also confirmed that the MR is highly unstable and requires special handling. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945398      PMCID: PMC3217130          DOI: 10.1016/j.steroids.2011.09.004

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  38 in total

Review 1.  Brain mineralocorticoid receptors and centrally regulated functions.

Authors:  E R de Kloet; S A Van Acker; R M Sibug; M S Oitzl; O C Meijer; K Rahmouni; W de Jong
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

Review 2.  Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.

Authors:  Morag J Young; John W Funder
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

Review 3.  Cell membrane-associated mineralocorticoid receptors? New evidence.

Authors:  Alexander W Krug; Luminita H Pojoga; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2011-04-11       Impact factor: 10.190

4.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

Authors:  J L Arriza; C Weinberger; G Cerelli; T M Glaser; B L Handelin; D E Housman; R M Evans
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

5.  A single-step technique for selecting and cloning hybridomas for monoclonal antibody production.

Authors:  J M Davis
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

6.  Interdomain interactions in the mineralocorticoid receptor.

Authors:  Fraser M Rogerson; Peter J Fuller
Journal:  Mol Cell Endocrinol       Date:  2003-02-28       Impact factor: 4.102

Review 7.  Nongenomic steroid action: controversies, questions, and answers.

Authors:  Ralf M Losel; Elisabeth Falkenstein; Martin Feuring; Armin Schultz; Hanns-Christian Tillmann; Karin Rossol-Haseroth; Martin Wehling
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

Review 8.  Mineralocorticoid receptor binding, structure and function.

Authors:  Fraser M Rogerson; Francine E Brennan; Peter J Fuller
Journal:  Mol Cell Endocrinol       Date:  2004-03-31       Impact factor: 4.102

9.  Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.

Authors:  Z S Krozowski; J W Funder
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Rapid corticosteroid-dependent regulation of mineralocorticoid receptor protein expression in rat brain.

Authors:  Brian A Kalman; Robert L Spencer
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

View more
  15 in total

1.  Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.

Authors:  Jessica A Chadwick; J Spencer Hauck; Jeovanna Lowe; Jeremiah J Shaw; Denis C Guttridge; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  FASEB J       Date:  2015-07-15       Impact factor: 5.191

2.  Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice.

Authors:  Jeovanna Lowe; Kyle T Floyd; Neha Rastogi; Eric J Schultz; Jessica A Chadwick; Sarah A Swager; Jonathan G Zins; Feni K Kadakia; Suzanne Smart; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Subha V Raman; Paul M L Janssen; Jill A Rafael-Fortney
Journal:  J Neuromuscul Dis       Date:  2016

Review 3.  Mineralocorticoid receptor activation as an etiological factor in kidney diseases.

Authors:  Kohei Ueda; Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2013-07-06       Impact factor: 2.801

4.  The selective mineralocorticoid receptor antagonist eplerenone prevents decompensation of the liver in cirrhosis.

Authors:  Barbara Schreier; Anja Wolf; Stefanie Hammer; Sabine Pohl; Sigrid Mildenberger; Sindy Rabe; Michael Gekle; Alexander Zipprich
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

5.  Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy.

Authors:  J Spencer Hauck; Jeovanna Lowe; Neha Rastogi; Kevin E McElhanon; Jennifer M Petrosino; Kyra K Peczkowski; Ashlee N Chadwick; Jonathan G Zins; Federica Accornero; Paul M L Janssen; Noah L Weisleder; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

Review 6.  The ubiquitous mineralocorticoid receptor: clinical implications.

Authors:  Urseline A Hawkins; Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

7.  Aldosterone Is Essential for Angiotensin II-Induced Upregulation of Pendrin.

Authors:  Daigoro Hirohama; Nobuhiro Ayuzawa; Kohei Ueda; Mitsuhiro Nishimoto; Wakako Kawarazaki; Atsushi Watanabe; Tatsuo Shimosawa; Takeshi Marumo; Shigeru Shibata; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2017-10-11       Impact factor: 10.121

8.  Expression of mineralocorticoid and glucocorticoid receptors in preautonomic neurons of the rat paraventricular nucleus.

Authors:  Jian Chen; Celso E Gomez-Sanchez; Alan Penman; Paul J May; Elise Gomez-Sanchez
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-31       Impact factor: 3.619

9.  The decrease of mineralcorticoid receptor drives angiogenic pathways in colorectal cancer.

Authors:  Laura Tiberio; Riccardo Nascimbeni; Vincenzo Villanacci; Claudio Casella; Anna Fra; Valeria Vezzoli; Lucia Furlan; Giuliano Meyer; Giovanni Parrinello; Maurizio D Baroni; Bruno Salerni; Luisa Schiaffonati
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

10.  RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.

Authors:  Ibrahim F Benter; Fawzi Babiker; Ibrahim Al-Rashdan; Mariam Yousif; Saghir Akhtar
Journal:  J Diabetes Res       Date:  2013-08-27       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.